IL6 and Parkinson disease: Besides, significantly greater CSF levels of transforming growth factor β1 (TGF-β1), IL-1β, and IL-6 were also observed in PD patients than those in controls, according to a systematic study of CSF cytokines in PD patients (Chen et al., 2018).